Humedics GmbH

Humedics GmbH: Revolutionizing Liver Function Measurement

Humedics GmbH is a biotechnology startup based in Berlin, Germany, founded in 2009. The company's slogan, "Quantifying functional liver capacity," encapsulates its core mission of providing rapid and accurate liver function measurement through innovative technology.

The company's flagship product, the LiMAx® test, is gaining widespread recognition for its ability to quantitatively assess an individual patient’s liver function capacity within minutes. This breakthrough technology empowers physicians to make informed decisions about treatment strategies and disease progression based on real-time data regarding the functional health of the liver.

Humedics GmbH's applications, published in prestigious medical journals, span a wide range, from liver function diagnosis before and after transplantation to surgical planning for liver surgery and assessment of liver diseases such as fibrosis and cirrhosis. More than 20 studies are currently underway, exploring new indications and further solidifying the potential of the LiMAx® test.

The LiMAx® test is already in routine clinical use at over 30 leading university hospitals in Europe, with over 20,000 tests performed to date. Moreover, it is commercially available in Germany, Austria, and the UK.

The company's growth and expansion received a significant boost with a €6.30M Series C investment from Seventure Partners, BioMed Partners, Peppermint Venture Partners, and Vesalius Biocapital on November 10, 2014.

Humedics GmbH's impactful technology and ongoing research initiatives position it as a key player in shaping the future of liver function assessment, with potential applications in areas such as chronic liver diseases and oncology treatment options. As the company continues to advance, its contributions to the medical field are poised to make a lasting impact on patient care and treatment outcomes.